Ebrahim Versi - May 25, 2023 Form 3 Insider Report for Adamis Pharmaceuticals Corp (ADMP)

Role
CEO, Director
Signature
/s/ David C. Benedicto, as Attorney-in-Fact
Stock symbol
ADMP
Transactions as of
May 25, 2023
Transactions value $
$0
Form type
3
Date filed
5/30/2023, 06:11 PM
Next filing
Sep 19, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney